Research field (2)：
Cardiology
, Healthcare management, medical sociology
Research keywords (6)：
Regulatory science
, Pharmacoepidemiology
, Meta-analysis
, Heart failure
, Heart rate variability
, Medical device development
Research theme for competitive and other funds (5)：
2023 - 2025 Development of surrogate endpoints for heart failure toward accelerated regulatory approval
2019 - 2022 The device lag and associated factors for innovative medical devices in Japan compared to the United States
2012 - 2015 Impact of the Great East Japan Earthquake on Heart Rate Variability
2004 - Clinical significance of heart rate variability in kidney transplant patients
2002 - Effects of aerobic exercise training on nonlinear dynamics and variability of heart rate in elderly people
Papers (83)：
Hidekatsu Fukuta, Toshihiko Goto, Takeshi Kamiya. Effects of beta-blocker withdrawal in patients with heart failure with preserved ejection fraction: A protocol for systematic review and meta-analysis. PLOS ONE. 2023. 18. 11. e0294347-e0294347
Hiromi Hagiwara, Takafumi Nakayama, Hiroya Hashimoto, Shigeru Kusumoto, Hidekatsu Fukuta, Takeshi Kamiya, Koichi Ikuta, Shinsuke Iida. Risk factors associated with overall survival in patients with multiple myeloma following carfilzomib treatment: A retrospective study from a large claims database in Japan. Cancer Medicine. 2023. 12. 19. 19361-19371
Hidekatsu Fukuta, Toshihiko Goto, Takeshi Kamiya. Association of epicardial fat with cardiac structure and function and cardiovascular outcomes: A protocol for systematic review and meta-analysis. PLOS ONE. 2023. 18. 4. e0283482-e0283482
Nobuyuki Ohte, Tomoko Ishizu, Chisato Izumi, Hiroshi Itoh, Shiro Iwanaga, Hiroyuki Okura, Yutaka Otsuji, Yasushi Sakata, Toshihiko Shibata, Toshiro Shinke, et al. JCS 2021 Guideline on the Clinical Application of Echocardiography. Circulation Journal. 2022. 86. 12. 2045-2119
Hidekatsu Fukuta, Hiromi Hagiwara, Takeshi Kamiya. Sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials. IJC Heart & Vasculature. 2022. 42. 101103-101103
2000 - 2004 Nagoya City University Graduate School of Medical Sciences
1989 - 1995 Nagoya City University Medical School
Professional career (1)：
Nagoya City University Graduate School of Medical Sciences/MD, PhD
Work history (7)：
2017/07 - 現在 Nagoya City University Hospital Clinical Research Management Center Vice Director
2015/07 - 2017/06 Pharmaceutical and Medical Devices Agency Office of Medical Devices Principal Reviewer
2006/09 - 2015/06 Nagoya City University Graduate School of Medical Sciences Department of Cardio-Renal Medicine and Hypertension Fellow/Assistant Professor
2004/09 - 2006/08 Wake Forest University Cardiology Section Research Fellow
2003/04 - 2004/08 Nagoya Rehabilitation and Sports Center Hospital Department of Internal Medicine Fellow
1996/07 - 2000/03 Narita Memorial Hospital Department of Cardiology Fellow
1995/05 - 1996/06 Nagoya City University Medical School Third Department of Internal Medicine Resident
Show all
Committee career (1)：
Scientific Reports (Nature publishing group) Editorial Board Member
Awards (5)：
2017 - Outstanding Reviewer Award (American Journal of Cardiology)
2017 - European Society of Cardiology Congress 2017 Best Poster Award
2015 - Outstanding Reviewer Award (International Journal of Cardiology)
2003 - Nagoya Ohjinkai Young Investigators Medical Research Award
2002 - Nagoya City University Medical Association Short-term Overseas Research Scholarship
Association Membership(s) (6)：
Society for Regulatory Science of Medical Products
, The American College of Physicians
, THE JAPANESE SOCIETY OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
, The Japanese Circulation Society
, The Japanese Society of Internal Medicine
, Japan Society of Clinical Trials and Research
